These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14648790)

  • 1. Statistical analysis of cytologic features useful in separation of metastatic urothelial carcinoma from other metastatic epithelial malignancies.
    Layfield LJ; Jones C; Hirschowitz S
    Diagn Cytopathol; 2003 Dec; 29(6):334-8. PubMed ID: 14648790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration diagnosis of metastatic urothelial carcinoma: a review.
    Cantley RL; Kapur U; Truong L; Cimbaluk D; Barkan GA; Wojcik E; Gattuso P
    Diagn Cytopathol; 2012 Feb; 40(2):173-8. PubMed ID: 22246936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
    Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
    Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of GLUT-1 immunolocalization in cell blocks: An adjunct to the fine needle aspiration diagnosis of cystic squamous lesions of the head and neck.
    Chandan VS; Faquin WC; Wilbur DC; Khurana KK
    Cancer; 2006 Apr; 108(2):124-8. PubMed ID: 16435376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytologic appearance of metastatic transitional cell carcinoma.
    Epstein NA
    Acta Cytol; 1977; 21(6):723-5. PubMed ID: 274878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic reliability of cytologic typing in primary lung cancer with a review of the literature.
    Suprun H; Pedio G; Ruttner JR
    Acta Cytol; 1980; 24(6):494-500. PubMed ID: 6255714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration cytology of metastatic transitional cell carcinoma.
    Dey P; Amir T; Jogai S; Al Jussar A
    Diagn Cytopathol; 2005 Apr; 32(4):226-8. PubMed ID: 15754372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
    Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
    Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomorphologic features of metastatic urothelial carcinoma in serous effusions.
    Huang CC; Attele A; Michael CW
    Diagn Cytopathol; 2013 Jul; 41(7):569-74. PubMed ID: 22833290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
    Chang YL; Lee YC; Liao WY; Wu CT
    Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade urothelial carcinoma: reappraisal of the cytologic criteria on ThinPrep.
    Xin W; Raab SS; Michael CW
    Diagn Cytopathol; 2003 Sep; 29(3):125-9. PubMed ID: 12951678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of cytologic diagnosis of early lung cancer.
    Vazquez MF; Koizumi JH; Henschke CI; Yankelevitz DF
    Cancer; 2007 Aug; 111(4):252-8. PubMed ID: 17614298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (ΔNp63) in squamous cell and urothelial carcinoma.
    Gailey MP; Bellizzi AM
    Am J Clin Pathol; 2013 Dec; 140(6):872-80. PubMed ID: 24225756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A morphologic and statistical comparative study of small-cell carcinoma and non-Hodgkin's lymphoma in fine-needle aspiration biopsy material from lymph nodes.
    De Las Casas LE; Gokden M; Mukunyadzi P; White P; Baker SJ; Hermonat PL; You H; Korourian S; Malak SF; Miranda RN
    Diagn Cytopathol; 2004 Oct; 31(4):229-34. PubMed ID: 15452900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cercariform cells: are they specific for transitional cell carcinoma?
    Hida CA; Gupta PK
    Cancer; 1999 Apr; 87(2):69-74. PubMed ID: 10227596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions.
    Caraway NP; Khanna A; Payne L; Kamat AM; Katz RL
    Cancer; 2007 Oct; 111(5):323-9. PubMed ID: 17721991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.